4 Followers USX:NTLA - Intellia Therapeutics, Inc Intellia Therapeutics, Inc
Sector: Health Care, Industry: Biotechnology
Next Earnings: 3 Nov 2021
Add to Watchlist
   
Add Alert 


Yahoo Finance (Live Price)

USD 137.71    -10.170 (-6.88%)
Show Technical Chart | 1M    3M    6M    1Y    3Y    5Y         

23 Jul 2021


Loading...
Loading...
Loading...

General

CEO: Dr. John M. Leonard

IPO: 2016-05-06

Headquarters: US

Employees: 312

Homepage

Description

Intellia Therapeutics Inc is a genome editing company. It is focused on developing proprietary, potentially curative CRISPR/Cas9-based therapeutics. Its pipeline includes in vivo development programs targeting genetic diseases, including transthyretin amyloidosis and hereditary angioedema, and ex vivo programs which include Acute Myeloid Leukemia.